CXCL10 Is Critical for the Progression and Maintenance of Depigmentation in a Mouse Model of Vitiligo

Worsening of Vitiligo and Onset of New Psoriasiform Dermatitis following Treatment with Infliximab

(2015) Khalid M. AlGhamdi et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

A CD8+/CD103high T Cell Subset Regulates TNF-Mediated Chronic Murine Ileitis

(2014) J. Ho et al.   JOURNAL OF IMMUNOLOGY

CXCL9 and CXCL10 Expression Are Critical for Control of Genital Herpes Simplex Virus Type 2 Infection through Mobilization of HSV-Specific CTL and NK Cells to the Nervous System

(2014) M. Thapa et al.   JOURNAL OF IMMUNOLOGY

T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo

(2013) Manoj Kumar Tembhre et al.   CLINICA CHIMICA ACTA

Vitiligo: interplay between oxidative stress and immune system

(2013) Naresh C. Laddha et al.   EXPERIMENTAL DERMATOLOGY

Peripheral Prepositioning and Local CXCL9 Chemokine-Mediated Guidance Orchestrate Rapid Memory CD8+ T Cell Responses in the Lymph Node

(2013) Wolfgang Kastenmüller et al.   IMMUNITY

Sensing and alarm function of resident memory CD8+ T cells

(2013) Jason M Schenkel et al.   NATURE IMMUNOLOGY

Memory T Cell Subsets, Migration Patterns, and Tissue Residence

(2012) Scott N. Mueller et al.   Annual Review of Immunology

A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection

(2012) Chung-Her Jenh et al.   BMC IMMUNOLOGY

Guidelines for the management of vitiligo: the European Dermatology Forum consensus

(2012) A. Taieb et al.   BRITISH JOURNAL OF DERMATOLOGY

Chemokine Guidance of Central Memory T Cells Is Critical for Antiviral Recall Responses in Lymph Nodes

(2012) Jung Hwan Sung et al.   CELL

CXCR3 Chemokine Receptor-Ligand Interactions in the Lymph Node Optimize CD4+ T Helper 1 Cell Differentiation

(2012) Joanna R. Groom et al.   IMMUNITY

Immune markers and differential signaling networks in ulcerative colitis and Crohnʼs disease

(2012) George P. Christophi et al.   INFLAMMATORY BOWEL DISEASES

Activation of the Unfolded Protein Response in Vitiligo: The Missing Link?

(2012) Thierry Passeron et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the Skin

(2012) John E. Harris et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Vitiligo-Inducing Phenols Activate the Unfolded Protein Response in Melanocytes Resulting in Upregulation of IL6 and IL8

(2012) Siavash Toosi et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Circulatory levels of T-cell cytokines (interleukin [IL]-2, IL-4, IL-17, and transforming growth factor-?) in patients with vitiligo

(2012) Rehan Khan et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases

(2012) David Wong et al.   PLoS One

Regulation of Antigen-Experienced T Cells: Lessons from the Quintessential Memory Marker CD44

(2012) Bas J. G. Baaten et al.   Frontiers in Immunology

Circulating chemokine (CXC motif) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10

(2011) Alessandro Antonelli et al.   CYTOKINE

CXCR3 ligands: redundant, collaborative and antagonistic functions

(2011) Joanna R Groom et al.   IMMUNOLOGY AND CELL BIOLOGY

Six Decades of Vitiligo Genetics: Genome-Wide Studies Provide Insights into Autoimmune Pathogenesis

(2011) Richard A. Spritz   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Vitiligo: A comprehensive overview

(2011) Lesley M. Felsten et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Vitiligo: A comprehensive overview

(2011) Ali Alikhan et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

HSP70i is a critical component of the immune response leading to vitiligo

(2011) Jeffrey A. Mosenson et al.   Pigment Cell & Melanoma Research

Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunity

(2011) Jasper G. van den Boorn et al.   Pigment Cell & Melanoma Research

Th17 Cells and Activated Dendritic Cells Are Increased in Vitiligo Lesions

(2011) Claire Q. F. Wang et al.   PLoS One

Vitiligo, reactive oxygen species and T-cells

(2010) Steven J. Glassman   CLINICAL SCIENCE

Mechanisms of Spatial and Temporal Development of Autoimmune Vitiligo in Tyrosinase-Specific TCR Transgenic Mice

(2010) Randal K. Gregg et al.   JOURNAL OF IMMUNOLOGY

Autoimmune Destruction of Skin Melanocytes by Perilesional T Cells from Vitiligo Patients

(2009) Jasper G. van den Boorn et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Vitiligo

(2009) Alain Taïeb et al.   NEW ENGLAND JOURNAL OF MEDICINE

Towards Small-Molecule CXCR3 Ligands with Clinical Potential

(2008) Maikel Wijtmans et al.   ChemMedChem

Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?

(2008) Lübeck Ralf Paus et al.   EXPERIMENTAL DERMATOLOGY

Protein kinase inhibitors substantially improve the physical detection of T-cells with peptide-MHC tetramers

(2008) Anna Lissina et al.   JOURNAL OF IMMUNOLOGICAL METHODS

An IFN-Associated Cytotoxic Cellular Immune Response against Viral, Self-, or Tumor Antigens Is a Common Pathogenetic Feature in “Interface Dermatitis”

(2008) Joerg Wenzel et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

CXCL9, but not CXCL10, Promotes CXCR3-Dependent Immune-Mediated Kidney Disease

(2008) J. Menke et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria

(2008) G. S. V. Campanella et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA